FIELD: medicine; pharmaceuticals.
SUBSTANCE: group of inventions relates to pharmaceutics, specifically to use of dioxidine for treating and/or preventing infectious-inflammatory epithelial injuries and wound healing, to a medicinal agent, pharmaceutical composition, a ready dosage form and a kit for treating and/or preventing infectious-inflammatory epithelial injuries and wound healing. Use of dioxydine involves local application of 0.001–0.4 wt/vol. % aqueous solution of dioxidine with pH from 3 to 7.5. Drug, pharmaceutical composition and the finished dosage form are aqueous 0.001–0.4 wt/vol. % dioxidine solution having pH of 3 to 7.5. Kit contains a bottle with a drug, a pharmaceutical composition or a ready dosage form, a nozzle and instructions for use.
EFFECT: group of inventions provides preserving the antimicrobial and anti-inflammatory activity of dioxidine in solutions, high photostability, high resistance to self-oxidation of dioxidine in solutions, high quality of dioxydine solutions and safety thereof due to the absence of microcrystals therein, accelerated healing of wounds and/or burns, recovery of damaged epithelium, reduced complications in treatment, provision of conditions for fast wound epithelisation, wider range of anti-infectious and anti-inflammatory topical agents for treating and/or preventing infectious-inflammatory epithelial injuries.
109 cl, 1 dwg, 6 ex, 4 tbl
| Title | Year | Author | Number | 
|---|---|---|---|
| LOCAL APPLICATION OF DIOXIDINE FOR INFLAMMATORY DISEASES OF GENITAL ORGANS AND PELVIC ORGANS | 2019 | 
 | RU2754102C2 | 
| NEW COMPOSITIONS OF 2,3-BIS-(HYDROXYMETHYL)QUINOXALINE 1,4-DI-N-OXIDE FOR TOPICAL APPLICATION | 2021 | 
 | RU2791248C2 | 
| LOCAL APPLICATION OF DIOXIDINE IN INFECTIOUS AND INFLAMMATORY DISEASES OF THE ORAL CAVITY | 2019 | 
 | RU2750668C2 | 
| ANTISEPTIC COMBINATION, ANTISEPTIC PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF | 2021 | 
 | RU2774622C1 | 
| ANTISEPTIC COMBINATION, ANTISEPTIC PHARMACEUTICAL COMPOSITION AND THEIR USE | 2022 | 
 | RU2797957C1 | 
| TOPICAL USE OF DIOXIDIN FOR TREATMENT OF OTOLARYNGOLOGICAL DISEASES | 2022 | 
 | RU2809120C1 | 
| TOPICAL USE OF DIOXIDIN FOR THE TREATMENT OF OTOLARYNGOLOGICAL DISEASES | 2018 | 
 | RU2801300C2 | 
| BISULPHAMINE AND DIOXIDIN OINTMENT FOR INTEGRATED TREATMENT OF INFECTIOUS INFLAMMATORY GYNAECOPATHIES | 2010 | 
 | RU2436567C1 | 
| PHARMACEUTICAL COMPOSITION FOR TREATING GYNAECOLOGICAL DISEASES IN COWS AND PIGS | 2021 | 
 | RU2776925C1 | 
| PHARMACEUTICAL COMBINED COMPOSITION FOR LOCAL AND EXTERNAL USE ON BASIS OF DIOXIDINE | 2016 | 
 | RU2667974C2 | 
Authors
Dates
2020-07-17—Published
2019-06-24—Filed